OBJECTIVES: To present the rationale, development, and pilot study of a medication adherence skills training (MAST-BD) intervention for older adults with bipolar disorder (BPD). We developed a 12-week manualized group intervention that combined educational, motivational, medication management skills and symptom management training adapted for older adults. METHODS: Among 21 older outpatients with BPD (mean age = 60 years; SD = 6), the feasibility and acceptability of MAST-BD were assessed in a quasi-experimental clinical trial. We also obtained preliminary effect sizes associated with pre-post change on measures of self-reported adherence to psychiatric medications, performance-based medication management ability, attitudes toward medication, depressive and manic symptoms, and health-related quality of life. RESULTS: At baseline, 55% of participants reported recent non-adherence to psychiatric medications and were, on average, suffering from moderately severe depressive symptoms and minimal symptoms of mania. A total of 76% of participants completed the intervention, and 86% of sessions were attended by completers. Participants reported high levels of satisfaction with the intervention and manual. Pre-post improvement by small to medium effect sizes (Cohen's d = 0.30-0.57) was seen in medication adherence, medication management ability, depressive symptoms, and selected indices of health-related quality of life. CONCLUSIONS: Notwithstanding the limitations of this small preliminary study, the results are encouraging in that the MAST-BD intervention was feasible, acceptable to patients, and associated with improvement in key outcomes. Suggestions for further development of medication adherence interventions for this neglected group of patients are discussed.
OBJECTIVES: To present the rationale, development, and pilot study of a medication adherence skills training (MAST-BD) intervention for older adults with bipolar disorder (BPD). We developed a 12-week manualized group intervention that combined educational, motivational, medication management skills and symptom management training adapted for older adults. METHODS: Among 21 older outpatients with BPD (mean age = 60 years; SD = 6), the feasibility and acceptability of MAST-BD were assessed in a quasi-experimental clinical trial. We also obtained preliminary effect sizes associated with pre-post change on measures of self-reported adherence to psychiatric medications, performance-based medication management ability, attitudes toward medication, depressive and manic symptoms, and health-related quality of life. RESULTS: At baseline, 55% of participants reported recent non-adherence to psychiatric medications and were, on average, suffering from moderately severe depressive symptoms and minimal symptoms of mania. A total of 76% of participants completed the intervention, and 86% of sessions were attended by completers. Participants reported high levels of satisfaction with the intervention and manual. Pre-post improvement by small to medium effect sizes (Cohen's d = 0.30-0.57) was seen in medication adherence, medication management ability, depressive symptoms, and selected indices of health-related quality of life. CONCLUSIONS: Notwithstanding the limitations of this small preliminary study, the results are encouraging in that the MAST-BD intervention was feasible, acceptable to patients, and associated with improvement in key outcomes. Suggestions for further development of medication adherence interventions for this neglected group of patients are discussed.
Authors: Colin A Depp; John L Stricker; David Zagorsky; Lisa C Goodale; Lisa T Eyler; Thomas L Patterson; Barry D Lebowitz; Dilip V Jeste Journal: Community Ment Health J Date: 2008-12-06
Authors: Chung-Ying Lin; Mehdi Yaseri; Amir H Pakpour; Dan Malm; Anders Broström; Bengt Fridlund; Andrea Burri; Thomas L Webb Journal: Drugs Aging Date: 2017-02 Impact factor: 3.923
Authors: Brent T Mausbach; Philip D Harvey; Ann E Pulver; Colin A Depp; Paula S Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Christopher R Bowie; Thomas L Patterson Journal: Bipolar Disord Date: 2010-02 Impact factor: 6.744
Authors: Colin A Depp; Jenni Ceglowski; Vicki C Wang; Faraz Yaghouti; Brent T Mausbach; Wesley K Thompson; Eric L Granholm Journal: J Affect Disord Date: 2014-11-08 Impact factor: 4.839
Authors: Colin A Depp; Ashley E Cain; Barton W Palmer; David J Moore; Lisa T Eyler; Barry D Lebowitz; Thomas L Patterson; Dilip V Jeste Journal: J Clin Psychopharmacol Date: 2008-04 Impact factor: 3.153